Evidence map›Paper›PMID 40933222›Full record

ArticleLe infezioni in medicina2025

A destruent case of recurrent primary naso-pharyngeal tuberculosis in a migrant.

Andrea Sergio Sarassi, Niccolò Riccardi, Giovanni Fumagalli, Alessandra Pelosi, Alice Claudia Repossi, Maurizio Ferrarese, Marco Mantero, Francesco Bruno Arturo Blasi, Luigi Ruffo Codecasa

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Le infezioni in medicina, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andrea Sergio SarassiDepartment of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Niccolò RiccardiStopTB Italia ODV, Milan, Italy.
Giovanni FumagalliDepartment of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Alessandra PelosiDermatology Outpatients Unit, Villa Marelli Institute, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Alice Claudia RepossiStopTB Italia ODV, Milan, Italy.
Maurizio FerrareseStopTB Italia ODV, Milan, Italy.
Marco ManteroDepartment of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Francesco Bruno Arturo BlasiDepartment of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Luigi Ruffo CodecasaStopTB Italia ODV, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 24-year-old Ukrainian man with post-natal developmental disability was treated for presumptive facial cutaneous TB in 2018 in his home country. After moving to Italy, his nostril lesion recurred in 2021, expanding to the upper lip, but he was lost to follow-up before a diagnosis was made. In 2023, when symptoms worsened, a biopsy was performed showing chronic inflammation and negative microbiological molecular tests and culture. By 2024, the lesion spread to the eyelids with worsening ulcerations. After surgical resection, histology revealed a vegetative, haemorrhagic mucosa with necrotic granulomatous inflammation and rifampin-susceptible

Indexed as

endemic countries: primary cutaneous tuberculosisrecurrent skin lesionsTB

Identifiers

PMID40933222
PMCPMC12419177

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.